The Use of Caffeine Citrate for Respiratory Stimulation in Acquired Central Hypoventilation Syndrome: A Case Series

1Schläfke ME, Pokorski M, See WR, Prill RK, Loeschcke HH. Chemosensitive neurons on the ventral medullary surface. Bull Physiopathol Respir (Nancy). 1975;11(2):277–84. Schläfke ME Pokorski M See WR Prill RK Loeschcke HH Chemosensitive neurons on the ventral medullary surface Bull Physiopathol Respir (Nancy) 1975112277 84Search in Google Scholar

2Demartini Junior Z, Gatto LAM, Koppe GL, Francisco AN, Guerios EE. Ondine’s curse: myth meets reality. Sleep Med: X 2. 2020;100012. Demartini Junior Z Gatto LAM Koppe GL Francisco AN Guerios EE Ondine’s curse: myth meets reality Sleep Med: X 2 202010001210.1016/j.sleepx.2020.100012804113233870169Search in Google Scholar

3Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006; 117(6):1979-87. Clark RH Bloom BT Spitzer AR Gerstmann DR Reported medication use in the neonatal intensive care unit: data from a large national data set Pediatrics 2006 117619798710.1542/peds.2005-170716740839Search in Google Scholar

4Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112–21. Schmidt B Roberts RS Davis P et al Caffeine therapy for apnea of prematurity N Engl J Med 2006354202112 2110.1056/NEJMoa05406516707748Search in Google Scholar

5Dobson NR, Hunt CE. Pharmacology review: caffeine use in neonates: indications, pharmacokinetics, clinical effects, outcomes. NeoReviews. 2003;14;e540-50. Dobson NR Hunt CE Pharmacology review: caffeine use in neonates: indications, pharmacokinetics, clinical effects, outcomes NeoReviews 200314e5405010.1542/neo.14-11-e540Search in Google Scholar

6Bellingham MC. Driving respiration: the respiratory central pattern generator. Clin Exp Pharmacol Physiol. 1998;25(10):847-56. Bellingham MC Driving respiration: the respiratory central pattern generator Clin Exp Pharmacol Physiol 199825108475610.1111/j.1440-1681.1998.tb02166.x9784928Search in Google Scholar

7Piper AJ, Yee BJ. Hypoventilation syndromes. Compr Physiol. 2014;4(4):1639-76. Piper AJ Yee BJ Hypoventilation syndromes Compr Physiol 20144416397610.1002/cphy.c14000825428856Search in Google Scholar

8Schrader L, Horsfall J, Bookheimer S. Use of caffeine during intraoperative awake language mapping. J Clin Neurophysiol. 2011;28(4):424–9. Schrader L Horsfall J Bookheimer S Use of caffeine during intraoperative awake language mapping J Clin Neurophysiol 2011284424 9Search in Google Scholar

9Gouda NM. Intravenous caffeine for adult patients with obstructive sleep apnea undergoing uvulopalatopharyngoplasty: effects on postoperative respiratory complications and recovery profile. Med J Cairo Univ. 2010;78:155–9. Gouda NM Intravenous caffeine for adult patients with obstructive sleep apnea undergoing uvulopalatopharyngoplasty: effects on postoperative respiratory complications and recovery profile Med J Cairo Univ 201078155 9Search in Google Scholar

10Warner NS, Warner MA, Schroeder DR, Sprung J, Weingarten TN. Effects of caffeine administration on sedation and respiratory parameters in patients recovering from anesthesia. Bosn J Basic Med Sci. 2018 Feb; 18(1): 101–104. Warner NS Warner MA Schroeder DR Sprung J Weingarten TN Effects of caffeine administration on sedation and respiratory parameters in patients recovering from anesthesia Bosn J Basic Med Sci 2018 Feb; 181 101 10410.17305/bjbms.2018.2434582666829206091Search in Google Scholar

11Fong R, Wang L, Zacny JP, Khokhar S, Apfelbaum JL, Fox AP, et al. Caffeine accelerates emergence from Isoflurane anesthesia in humans: a randomized, double-blind, crossover study. Anesthesiol. 2018;129(5):912–20. Fong R Wang L Zacny JP Khokhar S Apfelbaum JL Fox AP et al Caffeine accelerates emergence from Isoflurane anesthesia in humans: a randomized, double-blind, crossover study Anesthesiol 20181295912 2010.1097/ALN.0000000000002367619131630044241Search in Google Scholar

12Lexi-drugs online [database on the Internet]. Hudson (OH): Lexi-Comp, Inc.; 2019. Available from: http://online.lexi.com (Accessed on 19 Jan 2022). Lexi-drugs online [database on the Internet] Hudson (OH) Lexi-Comp, Inc 2019 Available from http://online.lexi.com (Accessedon 19 Jan 2022)Search in Google Scholar

13Bairam A, Uppari N, Mubayed S, Joseph V. An overview on the respiratory stimulant effects of caffeine and progesterone on response to hypoxia and apnea frequency in developing rats. Adv Exp Med Biol. 2015;860:211-20. Bairam A Uppari N Mubayed S Joseph V An overview on the respiratory stimulant effects of caffeine and progesterone on response to hypoxia and apnea frequency in developing rats Adv Exp Med Biol 20158602112010.1007/978-3-319-18440-1_2326303483Search in Google Scholar

14Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev. 2014;(12):CD009281. Derry CJ Derry S Moore RA Caffeine as an analgesic adjuvant for acute pain in adults Cochrane Database Syst Rev 201412CD00928110.1002/14651858.CD009281.pub3648570225502052Search in Google Scholar

15Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nature Reviews Neuroscience. 2003;4(5):399–415. Lo EH Dalkara T Moskowitz MA Mechanisms, challenges and opportunities in stroke Nature Reviews Neuroscience 200345399 41510.1038/nrn110612728267Search in Google Scholar

16Feeney D. M., Baron J. C. Diaschisis. Stroke. 1986;17(5):817– 830. Feeney D. M. Baron J. C. Diaschisis Stroke 1986175817 83010.1161/01.STR.17.5.8173532434Search in Google Scholar

17Dahan A, van der Schrier R, Smith T, Aarts L, van Velzen M, Niesters M. Averting opioid-induced respiratory depression without affecting analgesia. Anesthesiology. 2018;128:102737. Dahan A van der Schrier R Smith T Aarts L van Velzen M Niesters M. Averting opioid-induced respiratory depression without affecting analgesia Anesthesiology 201812810273710.1097/ALN.000000000000218429553984Search in Google Scholar

18Stanley NN, Galloway JM, Flint KC, Campbell DB. Increased respiratory chemosensitivity in patients with chronic airways obstruction. Br J Dis Chest. 1983;77:136-46. Stanley NN Galloway JM Flint KC Campbell DB Increased respiratory chemosensitivity in patients with chronic airways obstruction Br J Dis Chest 1983771364610.1016/0007-0971(83)90019-06871083Search in Google Scholar

19Gaudy JH, Dauthier C, Fourgeaux B. Effect of a new analeptic drug, almitrine, on fentanyl-induced respiratory depression and analgesia in man. Br J Anaesth. 1982;54:617-21. Gaudy JH Dauthier C Fourgeaux B Effect of a new analeptic drug, almitrine, on fentanyl-induced respiratory depression and analgesia in man Br J Anaesth 1982546172110.1093/bja/54.6.6176123336Search in Google Scholar

20European Medicines Agency Communication: Oral almitrine to be withdrawn by EU member states. EMEA/313994, 2013. [updated 2013 May 31; cited 2022 Feb 9]. Available from:www. ema.europa.eu/ema/index.jsp?curl=pages/medicines/ human/referrals/Almitrine/human_referral_prac_000011. jsp&mid=WC0b01ac05805c516f. European Medicines Agency Communication: Oral almitrine to be withdrawn by EU member states. EMEA/313994 2013 [updated 2013 May 31; cited 2022 Feb 9]. Available from www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Almitrine/human_referral_prac_000011 jsp&mid=WC0b01ac05805c516fSearch in Google Scholar

21Kim DW, Joo JD, In JH, Jeon YS, Jung HS, Jeon KB, Park JS, Choi JW. Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil. J Clin Anesth. 2013;25:173-6. Kim DW Joo JD In JH Jeon YS Jung HS Jeon KB Park JS Choi JW Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil J Clin Anesth 201325173610.1016/j.jclinane.2012.07.00523583458Search in Google Scholar

22Oertel BG, Schneider A, Rohrbacher M, Schmidt H, Tegeder I, Geisslinger G, Lotsch J. The partial 5-hydroxytryptamine 1A receptor agonist buspirone does not antagonize morphine induced respiratory depression in humans. Clin Pharmacol Ther. 2007;81:59-68. Oertel BG Schneider A Rohrbacher M Schmidt H Tegeder I Geisslinger G Lotsch J The partial 5-hydroxytryptamine 1A receptor agonist buspirone does not antagonize morphine induced respiratory depression in humans Clin Pharmacol Ther 200781596810.1038/sj.clpt.610001817186000Search in Google Scholar

23Lynch G. Glutamate-based therapeutic approaches: ampakines. Curr Opin Pharmacol. 2006;6:82-88. Lynch G Glutamate-based therapeutic approaches: ampakines Curr Opin Pharmacol 20066828810.1016/j.coph.2005.09.00516361116Search in Google Scholar

24Oertel BG, Felden L, Tran PV, Bradshaw MH, Angst MS, Schmidt H, Johnson S, Greer JJ, Geisslinger G, Varney MA, Lötsch J. Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia. Clin Pharmacol Ther. 2010;87(2):204-11. Oertel BG Felden L Tran PV Bradshaw MH Angst MS Schmidt H Johnson S Greer JJ Geisslinger G Varney MA Lötsch J Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia Clin Pharmacol Ther 20108722041110.1038/clpt.2009.19419907420Search in Google Scholar

25Mitchell RA, Herbert DA. Potencies of doxapram and hypoxia in stimulating carotid-body chemoreceptors and ventilation in anesthetized cats. Anesthesiology. 1975;42:559-66. Mitchell RA Herbert DA Potencies of doxapram and hypoxia in stimulating carotid-body chemoreceptors and ventilation in anesthetized cats Anesthesiology 1975425596610.1097/00000542-197505000-000091130721Search in Google Scholar

26Kim DW, Joo JD, In JH, Jeon YS, Jung HS, Jeon KB, Park JS, Choi JW. Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil. J Clin Anesth. 2013;25:173-6. Kim DW Joo JD In JH Jeon YS Jung HS Jeon KB Park JS Choi JW Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil J Clin Anesth 201325173610.1016/j.jclinane.2012.07.00523583458Search in Google Scholar

27Gairola RL, Gupta PK, Pandley K. Antagonists of morphine induced respiratory depression: a study in postoperative patients. Anaesthesia. 1980;35:17-21. Gairola RL Gupta PK Pandley K Antagonists of morphine induced respiratory depression: a study in postoperative patients Anaesthesia 198035172110.1111/j.1365-2044.1980.tb03714.x6994518Search in Google Scholar

28Roozekrans M, Olofsen E, van der Schrier R, Boom M, Mooren R, Dahan A. Doxapram-mediated increase in cardiac output reduces opioid plasma concentrations. A PK-PD/PK-PD modeling study in healthy volunteers. Clin Pharmacol Ther. 2017;102:115-22. Roozekrans M Olofsen E van der Schrier R Boom M Mooren R Dahan A Doxapram-mediated increase in cardiac output reduces opioid plasma concentrations. A PK-PD/PK-PD modeling study in healthy volunteers Clin Pharmacol Ther 20171021152210.1002/cpt.60128001306Search in Google Scholar

29Stephen CR, Talton I. Investigation of doxapram as a postanesthetic respiratory stimulant. Anesthesia & Analgesia. 1964;43:628-40. Stephen CR Talton I Investigation of doxapram as a postanesthetic respiratory stimulant Anesthesia & Analgesia 1964436284010.1213/00000539-196411000-00006Search in Google Scholar

30Abelson JL, Nesse RM, Weg JG, Curtis GC. Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic. Psychosomatic Medicine. 1996a;58:302-13. Abelson JL Nesse RM Weg JG Curtis GC Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic Psychosomatic Medicine 1996a583021310.1097/00006842-199607000-000028827792Search in Google Scholar

31Abelson JL, Weg JG, Nesse RM, Curtis GC. Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model. Psychoneuroendocrinology. 1996b;21:375-90. Abelson JL Weg JG Nesse RM Curtis GC Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model Psychoneuroendocrinology 1996b213759010.1016/0306-4530(96)00005-48844876Search in Google Scholar

32Miyata M, Hata T, Kato N, Takeuchi M, Mizutani H, Kubota M, Yamazaki T. Dynamic QT/RR relationship of cardiac conduction in premature infants treated with low-dose doxapram hydrochloride. Journal of Perinatal Medicine. 2007;35. Miyata M Hata T Kato N Takeuchi M Mizutani H Kubota M Yamazaki T Dynamic QT/RR relationship of cardiac conduction in premature infants treated with low-dose doxapram hydrochloride Journal of Perinatal Medicine 20073510.1515/JPM.2007.06817614751Search in Google Scholar

33Jonkman K, van Rijnsoever E, Olofsen E, et al. Esketamine counters opioid-induced respiratory depression. Br J Anaesth. 2018;120(5):1117-27. Jonkman K van Rijnsoever E Olofsen E et al Esketamine counters opioid-induced respiratory depression Br J Anaesth 2018120511172710.1016/j.bja.2018.02.02129661389Search in Google Scholar

34McCartney CE, McClafferty H, Huibant JM, Rowan EG, Shipston MJ, Rowe IC. A cysteine-rich motif confers hypoxia sensitivity to mammalian large conductance voltage- and Caactivated K (BK) channel alpha-subunits. Proc Natl Acad Sci USA. 2005;102:17870-6. McCartney CE McClafferty H Huibant JM Rowan EG Shipston MJ Rowe IC A cysteine-rich motif confers hypoxia sensitivity to mammalian large conductance voltage- and Caactivated K (BK) channel alpha-subunits Proc Natl Acad Sci USA 200510217870610.1073/pnas.0505270102130889316306267Search in Google Scholar

35Roozekrans M, van der Schrier R, Okkerse P, Hay J, McLeod JF, Dahan A. Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers. Anesthesiology. 2014;121:459-68. Roozekrans M van der Schrier R Okkerse P Hay J McLeod JF Dahan A Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers Anesthesiology 20141214596810.1097/ALN.000000000000036725222672Search in Google Scholar

36Roozekrans M, Olofsen E, van der Schrier R, van Gerven J, Peng S, McLeod J, Dahan A. Reversal of opioid-induced respiratory depression by BK-channel blocker GAL021: A pharmacokineticpharmacodynamic modeling study in healthy volunteers. Clin Pharmacol Ther. 2015;97:641-9. Roozekrans M Olofsen E van der Schrier R van Gerven J Peng S McLeod J Dahan A Reversal of opioid-induced respiratory depression by BK-channel blocker GAL021: A pharmacokineticpharmacodynamic modeling study in healthy volunteers Clin Pharmacol Ther 201597641910.1002/cpt.9925704491Search in Google Scholar